Which of the following is a red blood cell metabolic pathway involved in reducing methemoglobin?

Study for the Hematology 1 Test. Utilize flashcards and multiple-choice questions with detailed explanations. Prepare effectively for success!

Multiple Choice

Which of the following is a red blood cell metabolic pathway involved in reducing methemoglobin?

Methemoglobin reduction in red blood cells is handled mainly by a dedicated enzyme system that directly donates electrons to ferric iron (Fe3+) in methemoglobin, converting it back to ferrous iron (Fe2+) in hemoglobin. This Methemoglobin Reductase Pathway uses NADH produced by glycolysis to drive the electron transfer, keeping methemoglobin levels very low under normal conditions. The glycolytic source of NADH ties this process to the Embden-Meyerhof-Parnas pathway, so glycolysis supplies the reducing power for this critical repair mechanism. There is also a secondary NADPH-dependent route linked to the hexose monophosphate shunt that can assist methemoglobin reduction, especially under oxidative stress or with methylene blue therapy, but the primary endogenous mechanism is the Methemoglobin Reductase Pathway. The other options aren’t responsible for reducing methemoglobin directly: glycolysis provides NADH for the main system, the Rapaport-Luebering Shunt mainly alters 2,3-BPG and does not reduce methemoglobin, and the hexose monophosphate shunt’s NADPH-dependent route acts as a supplementary pathway rather than the principal mechanism.

Methemoglobin reduction in red blood cells is handled mainly by a dedicated enzyme system that directly donates electrons to ferric iron (Fe3+) in methemoglobin, converting it back to ferrous iron (Fe2+) in hemoglobin. This Methemoglobin Reductase Pathway uses NADH produced by glycolysis to drive the electron transfer, keeping methemoglobin levels very low under normal conditions. The glycolytic source of NADH ties this process to the Embden-Meyerhof-Parnas pathway, so glycolysis supplies the reducing power for this critical repair mechanism. There is also a secondary NADPH-dependent route linked to the hexose monophosphate shunt that can assist methemoglobin reduction, especially under oxidative stress or with methylene blue therapy, but the primary endogenous mechanism is the Methemoglobin Reductase Pathway. The other options aren’t responsible for reducing methemoglobin directly: glycolysis provides NADH for the main system, the Rapaport-Luebering Shunt mainly alters 2,3-BPG and does not reduce methemoglobin, and the hexose monophosphate shunt’s NADPH-dependent route acts as a supplementary pathway rather than the principal mechanism.

More practice questions